pv magazine International

Swiss researchers improve electrolyte design for long-life solid-state batteries

A Swiss research team has developed a low-temperature sintering and interface-coating process that significantly improves the ...

Solid Biosciences Receives FDA Orphan Drug Designation for SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

SGT-212 has received FDA Fast Track, Rare Pediatric Disease and Orphan Drug designations -- Dosing of the first participant in the Phase 1b ...

I swapped my coffee for Dose liver shots: Here’s the truth about the trendy supplement

Earlier this year, my wife and I welcomed our son into the world. While we are overjoyed with how happy and healthy he has ...

Solid Biosciences Doses First Participant in First-in-Class Phase 1b FALCON Trial Evaluating SGT-212 Dual-Route Gene Therapy for the Treatment of Friedreich’s Ataxia

About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...